KalVista Pharmaceuticals to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced it will participate in a fireside chat at the following investor conferences: Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022 at 1:50 p.m. EST Jefferies London Healthcare Conference on Thursday, November 17, 2022 at 8: